Stock Track | Guardant Health Soars 5% After Piper Sandler Reiterates Buy Rating

Stock Track

Aug 05, 2025

Shares of Guardant Health Inc. (GH) are soaring in Monday's intraday trading, registering a significant 5.02% increase. The surge comes as investors react positively to a recent analyst report.

Piper Sandler, a prominent financial services firm, has maintained its Buy rating on Guardant Health stock. In a report released earlier today, analyst David Westenberg reiterated the firm's bullish stance on the company, setting a price target of $60.00. This vote of confidence from a respected Wall Street firm appears to be driving the stock's upward momentum.

Guardant Health, known for its innovative liquid biopsy tests for cancer, has been attracting attention in the healthcare sector. The reaffirmation of the Buy rating suggests that Piper Sandler sees potential for further growth and value creation in the company. As investors digest this information, the stock's performance today indicates a positive market response to the analyst's outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1144441762"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144441762\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144441762?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 01:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144441762","market":"nz","top_or_hot":-1,"title":"Stock Track | Guardant Health Soars 5% After Piper Sandler Reiterates Buy Rating","media":"Stock Track","content":"<p>Shares of Guardant Health Inc. (GH) are soaring in Monday's intraday trading, registering a significant 5.02% increase. The surge comes as investors react positively to a recent analyst report.</p>\n\n<p>Piper Sandler, a prominent financial services firm, has maintained its Buy rating on Guardant Health stock. In a report released earlier today, analyst David Westenberg reiterated the firm's bullish stance on the company, setting a price target of $60.00. This vote of confidence from a respected Wall Street firm appears to be driving the stock's upward momentum.</p>\n\n<p>Guardant Health, known for its innovative liquid biopsy tests for cancer, has been attracting attention in the healthcare sector. The reaffirmation of the Buy rating suggests that Piper Sandler sees potential for further growth and value creation in the company. As investors digest this information, the stock's performance today indicates a positive market response to the analyst's outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Guardant Health Soars 5% After Piper Sandler Reiterates Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Guardant Health Soars 5% After Piper Sandler Reiterates Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-05 01:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Guardant Health Inc. (GH) are soaring in Monday's intraday trading, registering a significant 5.02% increase. The surge comes as investors react positively to a recent analyst report.</p>\n\n<p>Piper Sandler, a prominent financial services firm, has maintained its Buy rating on Guardant Health stock. In a report released earlier today, analyst David Westenberg reiterated the firm's bullish stance on the company, setting a price target of $60.00. This vote of confidence from a respected Wall Street firm appears to be driving the stock's upward momentum.</p>\n\n<p>Guardant Health, known for its innovative liquid biopsy tests for cancer, has been attracting attention in the healthcare sector. The reaffirmation of the Buy rating suggests that Piper Sandler sees potential for further growth and value creation in the company. As investors digest this information, the stock's performance today indicates a positive market response to the analyst's outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GH","symbol_name":"Guardant Health Inc.","start_time":0,"source_url":"","article_id":"1144441762","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144441762","pubTimestamp":1754327665,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Guardant Health Inc. (GH) are soaring in Monday's intraday trading, registering a significant 5.02% increase. The surge comes as investors react positively to a recent analyst report....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GH":"Guardant Health Inc."},"translate_title":"个股追踪|Piper Sandler重申买入评级后Guardant Health股价飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GH":1},"content_text":"Shares of Guardant Health Inc. (GH) are soaring in Monday's intraday trading, registering a significant 5.02% increase. The surge comes as investors react positively to a recent analyst report.\nPiper Sandler, a prominent financial services firm, has maintained its Buy rating on Guardant Health stock. In a report released earlier today, analyst David Westenberg reiterated the firm's bullish stance on the company, setting a price target of $60.00. This vote of confidence from a respected Wall Street firm appears to be driving the stock's upward momentum.\nGuardant Health, known for its innovative liquid biopsy tests for cancer, has been attracting attention in the healthcare sector. The reaffirmation of the Buy rating suggests that Piper Sandler sees potential for further growth and value creation in the company. As investors digest this information, the stock's performance today indicates a positive market response to the analyst's outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}